Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Terminated1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation
Alpha 1-Antitrypsin DeficiencyAneurysmCystic Fibrosis+1 more
PrincipalinvestigatorStart date: 2017-10-31
NCT01743755Phase 4Terminated
Santeon-CAP; Dexamethasone in Community-acquired Pneumonia
Community-acquired Pneumonia
Principalinvestigator

Research Network

Collaboration Network

7 collaborators·21 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Bresser, MD, PhD

Onze Lieve Vrouwen Gasthuis

Related
1 trials

Shared therapeutic areas:

Community-Acquired Pneumonia

Worked with same sponsors:

Canisius-Wilhelmina HospitalCatharina Ziekenhuis Eindhoven+3 more
Collaborated on 1 trial
Similarity Score14%

Willem Jan Bos, MD, PhD

St. Antonius Hospital

Related
1 trials

Shared therapeutic areas:

Community-Acquired Pneumonia

Worked with same sponsors:

Canisius-Wilhelmina HospitalCatharina Ziekenhuis Eindhoven+3 more
Collaborated on 1 trial
Similarity Score14%

Stijn Konings, MD, PhD

Catharina Ziekenhuis Eindhoven

Related
1 trials

Shared therapeutic areas:

Community-Acquired Pneumonia

Worked with same sponsors:

Canisius-Wilhelmina HospitalCatharina Ziekenhuis Eindhoven+3 more
Collaborated on 1 trial
Similarity Score14%

Frank Smeenk, MD, PhD

Catharina Ziekenhuis Eindhoven

Related
1 trials

Shared therapeutic areas:

Community-Acquired Pneumonia

Worked with same sponsors:

Canisius-Wilhelmina HospitalCatharina Ziekenhuis Eindhoven+3 more
Collaborated on 1 trial
Similarity Score14%

Willem Blok, MD, PhD

Onze Lieve Vrouwen Gasthuis

Related
1 trials

Shared therapeutic areas:

Community-Acquired Pneumonia

Worked with same sponsors:

Canisius-Wilhelmina HospitalCatharina Ziekenhuis Eindhoven+3 more
Collaborated on 1 trial
Similarity Score14%

Jan Grutters, Prof, MD

St. Antonius Hospital

Related
1 trials

Shared therapeutic areas:

Community-Acquired Pneumonia

Worked with same sponsors:

Canisius-Wilhelmina HospitalCatharina Ziekenhuis Eindhoven+3 more
Collaborated on 1 trial
Similarity Score14%

Ed Doo, MD

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
13 trials

Shared therapeutic areas:

alpha 1-Antitrypsin DeficiencyCystic Fibrosis
Similarity Score12%

Sheila M. Innis, Dr.

University of British Columbia

Related
6 trials

Shared therapeutic areas:

Cystic Fibrosis
Similarity Score6%

Shawn Aaron, MD

The Ottawa Hospital

Related
2 trials

Shared therapeutic areas:

Cystic Fibrosis
Similarity Score6%

Rémi Rabasa-Lhoret

Institut de Recherches Cliniques de Montreal

Related
16 trials

Shared therapeutic areas:

Cystic Fibrosis
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03285100PrincipalInvestigator

The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation

Alpha 1-Antitrypsin DeficiencyAneurysmCystic Fibrosis+1 more
Unknown
NCT01743755Phase 4PrincipalInvestigator

Santeon-CAP; Dexamethasone in Community-acquired Pneumonia

Community-acquired Pneumonia
Terminated

All 2 trials loaded